Clik here to view.
GenScript ProBio Signs Viral Vector Manufacturing MOU With Curocell for...
SEOUL, South Korea On November 10, a global multimodality CDMO, GenScript ProBio and specialized CAR-T therapy firm Curocell signed a strategic partnership MOU for the production of viral vectors...
View ArticleClik here to view.
武田薬品、前治療歴のある転移性結腸直腸がんに対するFRUZAQLA™（フルキンニチブ）の米国FDA承認を得る
大阪、マサチューセッツ州ケンブリッジ （ビジネスワイヤ） — 武田薬品工業株式会社（「武田薬品」、TSE:4502/NYSE:TAK）は、以前フルオロピリミジン、オキサリプラチン、イリノテカンをベースとした化学療法、対VEGF療法、およびRAS...
View ArticleClik here to view.
冠科生物推出OrganoidXplore平台:利用高效的大规模类器官药物筛选技术引领革命性癌症研究
圣地亚哥，美国 (美国商业资讯)– 冠科生物为JSR生命科学集团旗下全球合同研究组织(CRO)子公司，今日宣布推出一项突破性的服务——OrganoidXploreTM，一个大规模类器官panel筛选平台。该平台承诺将以创纪录的速度输出稳健、可重复及临床相关的数据，通过赋能研究人员重塑癌症治疗发展的格局来加速临床前肿瘤药物的发现。 使用冠科生物独特的即用型(Assay...
View ArticleClik here to view.
Aurinia Pharmaceuticals Announces Collaboration Partner Otsuka Filed New Drug...
ROCKVILLE, Md. & EDMONTON, Alberta Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today announced that the Company’s collaboration partner, Otsuka Pharmaceutical Ltd.,...
View ArticleClik here to view.
Global Coalition for Adaptive Research in Collaboration with Cure Brain...
LARKSPUR, Calif. The Global Coalition for Adaptive Research (GCAR) in collaboration with Cure Brain Cancer Foundation (CBCF), today announced the opening of GBM AGILE (Glioblastoma Adaptive Global...
View ArticleClik here to view.
10 Studies on InnoCare’s Oncology Pipelines Selected at the Upcoming 65th...
BEIJING InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that 10 studies from InnoCare’s...
View ArticleClik here to view.
BeiGene Receives European Commission Approval for BRUKINSA® (zanubrutinib)...
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass. BeiGene, Ltd. (Nasdaq: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced that the European Commission (EC) has...
View ArticleClik here to view.
Genome Insight to Unveil Hong Kong Real-World Evidence on Target Enhanced...
SAN DIEGO Genome Insight, a precision healthcare solutions company advancing whole-genome technology for accurate diagnosis and personalized treatment for cancer and rare disease, will announce...
View ArticleClik here to view.
Guided Therapeutics Announces Completion of Clinical Study for Chinese...
PEACHTREE CORNERS, Ga. Guided Therapeutics, Inc. (OTCQB: GTHP) announced today the completion of the clinical trial for marketing and sales approval of the Company’s LuViva Advanced Cervical Scan by...
View ArticleClik here to view.
アストラゼネカ、医療技術ビジネスであるEvinova（エヴィノバ）を立ち上げ、ライフサイエンス分野全体のイノベーション、臨床試験の提供、より良い健康成果を加速
デラウェア州ウィルミントン （ビジネスワイヤ） —...
View ArticleClik here to view.
IASO Bio Establishes International CAR-T Diagnostic and Treatment Center in...
NANJING, China Nanjing IASO Biotechnology Co., Ltd. (IASO Bio) made its debut at the 6th China International Import Expo (CIIE) with FUCASO, the world’s first fully-human CAR-T, and entered into a...
View ArticleClik here to view.
AstraZeneca成立健康科技公司Evinova，旨在加速生命科学领域的创新、临床试验的开展和更好的医疗效果
特拉华州威尔明顿 (美国商业资讯)– AstraZeneca今日宣布成立Evinova。Evinova将成为数字医疗解决方案的领先供应商，以更好地满足医疗保健专业人士、监管机构和患者的需求。依托AstraZeneca的长期支持以及与Parexel和Fortrea的战略合作，Evinova将为生命科学和医疗保健行业提供全球规模的数字产品和服务。...
View ArticleClik here to view.
BeiGene and Ensem Therapeutics Announce Partnership to Advance Differentiated...
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass. & WALTHAM, Mass. BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, and Ensem Therapeutics, Inc....
View ArticleClik here to view.
AnHeart Therapeutics and Innovent Announce China’s NMPA Has Accepted a New...
NEW YORK & SUZHOU, China AnHeart Therapeutics (“AnHeart”), a global clinical-stage biopharmaceutical company developing novel precision therapies for people with cancer, and Innovent Biologics,...
View ArticleClik here to view.
Takeda to Present Data at 65th American Society of Hematology (ASH) Annual...
OSAKA, Japan & CAMBRIDGE, Mass. Takeda (TSE:4502/NYSE:TAK) today announced that it will present 17 company-sponsored abstracts at the 65th American Society of Hematology (ASH) Annual Meeting...
View ArticleClik here to view.
BeiGene to Present New Data Highlighting Hematology Portfolio and Pipeline...
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass. BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced the presentation of new data across a...
View ArticleClik here to view.
BioSkryb Genomics Appoints Genomics Industry Veteran Ram Laxman as Chief...
DURHAM, N.C. BioSkryb Genomics, a company transforming single-cell analysis by enabling the most complete multiomic view of the cellular ecosystem, from discovery to diagnostics, has appointed Ram...
View ArticleClik here to view.
BeiGene to Host ASH Investor Meeting in Person and via Webcast on December...
BASEL, Switzerland & BEIJING & CAMBRIDGE, Mass. BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced that it will host an Investor Event at...
View ArticleClik here to view.
FDA Grants Priority Review for Supplemental Biologics License Application...
BOTHELL, Wash. & TOKYO Seagen Inc. (Nasdaq: SGEN) and Astellas Pharma Inc. (TSE:4503) today announced that on November 30, 2023 the U.S. Food and Drug Administration (FDA) accepted for priority...
View ArticleClik here to view.
Perpetual Medicines Completes $8 Million Seed Round to Advance Integrated...
SHANGHAI & BOSTON Perpetual Medicines today announced it has closed an $8 million seed financing to advance its integrated computational design and synthesis platform for peptide drug discovery....
View Article